Related Experiment Video
Updated: Aug 30, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Long Noncoding RNA FBXL19-AS1-Mediated Ulcerative Colitis-Associated Intestinal Epithelial Barrier Defect
Xun Zhao1, De-Jun Cui2, Liu-Chan Yang2
1Department of Gastroenterology, Guizhou Provincial People's Hospital, Medical College of Guizhou University, No. 83, East Zhongshan Road, Guiyang City, 550002, Guizhou Province, China. zxun025@outlook.com.
Long non-coding RNA FBXL19 antisense RNA 1 (FBXL19-AS1) exacerbates ulcerative colitis (UC) by reducing miR-339-3p, which targets RHOB. Inhibiting FBXL19-AS1 ameliorates UC in a mouse model.
Area of Science:
- Gastroenterology
- Molecular Biology
- RNA Biology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- The role of long non-coding RNAs (lncRNAs) in UC pathogenesis is increasingly recognized.
- FBXL19 antisense RNA 1 (FBXL19-AS1) is a lncRNA whose function in UC remains unclear.
Purpose of the Study:
- To investigate the role of FBXL19-AS1 in the development of ulcerative colitis (UC).
- To elucidate the underlying molecular mechanism of FBXL19-AS1 in UC.
- To explore the potential of targeting FBXL19-AS1 for UC treatment.
Main Methods:
- FBXL19-AS1 expression analysis in UC patients and a dextran sodium sulfate (DSS)-induced mouse colitis model.
- Assessment of colonic histopathology, apoptosis, fibrosis, and intestinal permeability in mice.
- Enzyme-linked immunosorbent assay (ELISA) for inflammatory cytokines (IL-1β, IL-18).
- RNA immunoprecipitation and dual luciferase reporter assays to confirm molecular interactions.
Main Results:
- FBXL19-AS1 expression was significantly upregulated in DSS-induced colitis.
- FBXL19-AS1 interference or miR-339-3p overexpression attenuated colonic inflammation, apoptosis, and barrier defects in mice.
- FBXL19-AS1 acts as a sponge for miR-339-3p, and miR-339-3p targets RHOB.
- RHOB overexpression counteracted the protective effects of FBXL19-AS1 inhibition.
Conclusions:
- FBXL19-AS1 promotes UC development by sponging miR-339-3p, thereby relieving RHOB inhibition.
- FBXL19-AS1 aggravates intestinal epithelial barrier defects in DSS-induced colitis.
- Targeting FBXL19-AS1 may represent a therapeutic strategy for ulcerative colitis.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Renewal of Intestinal Stem Cells
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

